StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3070% below fair value
$0.19−0.00 (-1.01%)

Close on Nov 18, 2026Market cap $2.37MP/E –Yield –

20/20 Biolabs free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for 20/20 Biolabs

20/20 Biolabs has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More 20/20 Biolabs figures

See a number that looks wrong?